From Glofish to Frankenfish: Understanding How the Approval of Transgenic Animals May Impact Animal and Human Food and Drugs

September 14, 2016 9:30am

Joseph W. Cormier
Attorney
Hyman, Phelps & McNamara, P.C. (Washington, DC)

GMO Salmon was approved for human consumption last fall via a New Animal Drug Application. This panel will explore the controversial nature of this approval as well as its wider implication for animal and human food and drugs.

  • Review and analysis of the approval process for transgenic animals through use of a NADA
    • understanding why a potential food is approved as an animal drug
  • Glofish exemption v. AquAdvantage NADA Approval
    • differences and controversies
  • Implications for what new animal drug approval for transgenic animals such as AquAdvantage salmon will have on animal and human foods chain
  • Exploring the labeling controversy for AquAdvantage salmon and other GMO foods in both the animal and human food industries